Vasodilators and low-dose acetylsalicylic acid are associated with a lower incidence of distinct primary myocardial disease manifestations in systemic sclerosis: results of the DeSScipher inception cohort study
Gabriele Valentini*, Dörte Huscher, Antonella Riccardi, Serena Fasano, Rosaria Irace, Valentina Messiniti, Marco Matucci-Cerinic, Serena Guiducci, Oliver Distler, Britta Maurer, Jérôme Avouac, Ingo H. Tarner, Marc Frerix, Gabriela Riemekasten, Elise Siegert, László Czirják, Veronika Lóránd, Christopher P. Denton, Svetlana Nihtyanova, Ulrich A. Walker
*Corresponding author for this work
- Second University of Naples
- Charite - Universitatsmedizin Berlin
- University of Florence
- Zurich Center for Integrative Human Physiology (ZIHP)
- Université Paris Descartes
- University of Giessen
- University of Pécs
- University of London
- University of Basel
- University of Leeds, School of Medicine
- VA Nasonova Institute of Rheumatology
- ‘Carol Davila’ University of Medicine and Pharmacy
- University of Tubingen
- St. Josef Hospital Wuppertal
- University of Cagliari
- Sechenov First Moscow State Medical University
- Hamburger Zentrum für Kinder- und Jugendrheumatologie
- Università Politecnica delle Marche
- University of Medicine and Pharmacy
42
Link opens in a new tab
Citations
(Scopus)